Strategic Assessment of Metabolic vs. Genetic Healthcare Innovations
Executive Summary
Metabolic therapies and AI-driven genetic solutions represent two divergent paths in modern healthcare innovation. While ketogenic metabolic therapy (KMT) demonstrates clinical promise—particularly for mental health—it faces systemic adoption barriers. Meanwhile, the $500 billion Stargate Project, spearheaded by tech giants and politi…
Keep reading with a 7-day free trial
Subscribe to Paul J. Swider to keep reading this post and get 7 days of free access to the full post archives.